
As part of our coverage of the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, we discuss how molecular diagnosis in medulloblastoma affects clinical decision-making.

Your AI-Trained Oncology Knowledge Connection!


Published: May 28th 2014 | Updated: